LAMP3 expression correlated with poor clinical outcome in human ovarian cancer

Lysosome-associated membrane protein 3 belongs to the lysosome-associated membrane glycoprotein family, which is associated with lymph node, metastasis, poor overall survival, and resistance to chemotherapy and radiotherapy. Epithelial ovarian cancer is one of the most deadly global female gynecolog...

Full description

Saved in:
Bibliographic Details
Main Authors: Di Wang, Xuemin Cao, Yuquan Zhang, Yuanlin Liu, Chan Yao, Wenliang Ge, Yunzhao Xu
Format: Article
Language:English
Published: SAGE Publishing 2017-03-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428317695014
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839596000231030784
author Di Wang
Xuemin Cao
Yuquan Zhang
Yuanlin Liu
Chan Yao
Wenliang Ge
Yunzhao Xu
author_facet Di Wang
Xuemin Cao
Yuquan Zhang
Yuanlin Liu
Chan Yao
Wenliang Ge
Yunzhao Xu
author_sort Di Wang
collection DOAJ
description Lysosome-associated membrane protein 3 belongs to the lysosome-associated membrane glycoprotein family, which is associated with lymph node, metastasis, poor overall survival, and resistance to chemotherapy and radiotherapy. Epithelial ovarian cancer is one of the most deadly global female gynecologic malignant tumors. Its clinical outcome is poor and most epithelial ovarian cancer patients tend to relapse because of drug resistance. However, lysosome-associated membrane protein 3 expression in epithelial ovarian cancer and its relationship between clinicopathologic factors remain poorly understood. To clarify the prognostic implications of lysosome-associated membrane protein 3 in epithelial ovarian cancer, we analyzed both messenger RNA and protein levels of lysosome-associated membrane protein 3 in ovarian carcinomas. Polymerase chain reaction results showed higher expression of lysosome-associated membrane protein 3 messenger RNA in epithelial ovarian cancer than in noncancerous tissues. Immunohistochemical results showed that high lysosome-associated membrane protein 3 cytoplasmic expression was significantly related to tumor grade ( p  = 0.038), lymph node metastasis ( p  = 0.049), metastasis ( p  < 0.001), level of CA125 ( p  = 0.030), and International Federation of Gynecology and Obstetrics (FIGO) ( p  < 0.001). High lysosome-associated membrane protein 3 nuclear expression was significantly associated with tumor grade ( p  = 0.046), tumor single or double (representative whether the tumor involving one or both ovaries) ( p  = 0.016), metastasis ( p  < 0.001), and FIGO stage ( p  < 0.001). Survival analysis indicated that high lysosome-associated membrane protein 3 cytoplasmic expression (hazard ratio: 4.632, 95% confidence interval: 2.421–8.864; p  < 0.001), patients’ age (hazard ratio: 1.729, 95% confidence interval: 1.027–2.911; p  = 0.039), and FIGO stage (hazard ratio: 2.049, 95% confidence interval: 1.113–3.774; p  = 0.021) were significantly correlated with poor survival outcome of epithelial ovarian cancer patients.
format Article
id doaj-art-e779f996c0714ecf8e2b29d577a4e910
institution Matheson Library
issn 1423-0380
language English
publishDate 2017-03-01
publisher SAGE Publishing
record_format Article
series Tumor Biology
spelling doaj-art-e779f996c0714ecf8e2b29d577a4e9102025-08-02T22:11:45ZengSAGE PublishingTumor Biology1423-03802017-03-013910.1177/1010428317695014LAMP3 expression correlated with poor clinical outcome in human ovarian cancerDi Wang0Xuemin Cao1Yuquan Zhang2Yuanlin Liu3Chan Yao4Wenliang Ge5Yunzhao Xu6Department of Obstetrics and Gynecology, Affiliated Hospital of Nantong University, Nantong, ChinaDepartment of Biology, Nantong University, Nantong, ChinaDepartment of Obstetrics and Gynecology, Affiliated Hospital of Nantong University, Nantong, ChinaDepartment of Obstetrics and Gynecology, Affiliated Hospital of Nantong University, Nantong, ChinaDepartment of Pathology, Affiliated Hospital of Nantong University, Nantong, ChinaDepartment of Pediatric Surgery, Affiliated Hospital of Nantong University, Nantong, ChinaDepartment of Obstetrics and Gynecology, Affiliated Hospital of Nantong University, Nantong, ChinaLysosome-associated membrane protein 3 belongs to the lysosome-associated membrane glycoprotein family, which is associated with lymph node, metastasis, poor overall survival, and resistance to chemotherapy and radiotherapy. Epithelial ovarian cancer is one of the most deadly global female gynecologic malignant tumors. Its clinical outcome is poor and most epithelial ovarian cancer patients tend to relapse because of drug resistance. However, lysosome-associated membrane protein 3 expression in epithelial ovarian cancer and its relationship between clinicopathologic factors remain poorly understood. To clarify the prognostic implications of lysosome-associated membrane protein 3 in epithelial ovarian cancer, we analyzed both messenger RNA and protein levels of lysosome-associated membrane protein 3 in ovarian carcinomas. Polymerase chain reaction results showed higher expression of lysosome-associated membrane protein 3 messenger RNA in epithelial ovarian cancer than in noncancerous tissues. Immunohistochemical results showed that high lysosome-associated membrane protein 3 cytoplasmic expression was significantly related to tumor grade ( p  = 0.038), lymph node metastasis ( p  = 0.049), metastasis ( p  < 0.001), level of CA125 ( p  = 0.030), and International Federation of Gynecology and Obstetrics (FIGO) ( p  < 0.001). High lysosome-associated membrane protein 3 nuclear expression was significantly associated with tumor grade ( p  = 0.046), tumor single or double (representative whether the tumor involving one or both ovaries) ( p  = 0.016), metastasis ( p  < 0.001), and FIGO stage ( p  < 0.001). Survival analysis indicated that high lysosome-associated membrane protein 3 cytoplasmic expression (hazard ratio: 4.632, 95% confidence interval: 2.421–8.864; p  < 0.001), patients’ age (hazard ratio: 1.729, 95% confidence interval: 1.027–2.911; p  = 0.039), and FIGO stage (hazard ratio: 2.049, 95% confidence interval: 1.113–3.774; p  = 0.021) were significantly correlated with poor survival outcome of epithelial ovarian cancer patients.https://doi.org/10.1177/1010428317695014
spellingShingle Di Wang
Xuemin Cao
Yuquan Zhang
Yuanlin Liu
Chan Yao
Wenliang Ge
Yunzhao Xu
LAMP3 expression correlated with poor clinical outcome in human ovarian cancer
Tumor Biology
title LAMP3 expression correlated with poor clinical outcome in human ovarian cancer
title_full LAMP3 expression correlated with poor clinical outcome in human ovarian cancer
title_fullStr LAMP3 expression correlated with poor clinical outcome in human ovarian cancer
title_full_unstemmed LAMP3 expression correlated with poor clinical outcome in human ovarian cancer
title_short LAMP3 expression correlated with poor clinical outcome in human ovarian cancer
title_sort lamp3 expression correlated with poor clinical outcome in human ovarian cancer
url https://doi.org/10.1177/1010428317695014
work_keys_str_mv AT diwang lamp3expressioncorrelatedwithpoorclinicaloutcomeinhumanovariancancer
AT xuemincao lamp3expressioncorrelatedwithpoorclinicaloutcomeinhumanovariancancer
AT yuquanzhang lamp3expressioncorrelatedwithpoorclinicaloutcomeinhumanovariancancer
AT yuanlinliu lamp3expressioncorrelatedwithpoorclinicaloutcomeinhumanovariancancer
AT chanyao lamp3expressioncorrelatedwithpoorclinicaloutcomeinhumanovariancancer
AT wenliangge lamp3expressioncorrelatedwithpoorclinicaloutcomeinhumanovariancancer
AT yunzhaoxu lamp3expressioncorrelatedwithpoorclinicaloutcomeinhumanovariancancer